Evidence map›Paper›PMID 29884199›Full record

ArticleArthritis research & therapy2018

Smoking-induced aggravation of experimental arthritis is dependent of aryl hydrocarbon receptor activation in Th17 cells.

Jhimmy Talbot, Raphael S Peres, Larissa G Pinto, Rene D R Oliveira, Kalil A Lima, Paula B Donate, Jaqueline R Silva, Bernard Ryffel, Thiago M Cunha, José C Alves-Filho and 3 more

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Effect of polycyclic aromatic hydrocarbons on immunity.Journal of translational autoimmunity · 2022
    Article
  18. 6-Formylindolo[3,2-Frontiers in toxicology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 4 countries.

Jhimmy TalbotDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto, SP, 14049900, Brazil.
Raphael S PeresDepartment of Immunology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.
Larissa G PintoDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto, SP, 14049900, Brazil.
Rene D R OliveiraDivision of Clinical Immunology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.
Kalil A LimaDepartment of Immunology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.
Paula B DonateDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto, SP, 14049900, Brazil.
Jaqueline R SilvaDepartment of Immunology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.
Bernard RyffelUniversité Orleans and Centre National de la Recherche Scientifique, Molecular Immunology, UMR7355, INEM, Orleans, France.
Thiago M CunhaDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto, SP, 14049900, Brazil.
José C Alves-FilhoDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto, SP, 14049900, Brazil.
Foo Y LiewDivision of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, G12 8TA, UK. foo.liew@glasgow.ac.uk.
Paulo Louzada-JuniorDivision of Clinical Immunology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil. plouzada@fmrp.usp.br.
Fernando de Queiroz CunhaDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto, SP, 14049900, Brazil. fdqcunha@fmrp.usp.br.
Universidade de São Paulo · BRImmunologie et Neurogénétique Expérimentales et Moléculaires · FRUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiologic studies have highlighted the association of environmental factors with the development and progression of autoimmune and chronic inflammatory diseases. Among the environmental factors, smoking has been associated with increased susceptibility and poor prognosis in rheumatoid arthritis (RA). However, the immune and molecular mechanism of smoking-induced arthritis aggravation remains unclear. The transcription factor aryl hydrocarbon receptor (AHR) regulates the generation of Th17 cells, CD4 T cells linked the development of autoimmune diseases. AHR is activated by organic compounds including polycyclic aromatic hydrocarbons (PAHs), which are environmental pollutants that are also present in cigarette smoke. In this study, we investigated the role of AHR activation in the aggravation of experiment arthritis induced by exposure to cigarette smoke.

methodsMice were exposed to cigarette smoke during the developmental phase of antigen-induced arthritis and collagen-induced arthritis to evaluate the effects of smoking on disease development. Aggravation of articular inflammation was assessed by measuring neutrophil migration to the joints, increase in articular hyperalgesia and changes in the frequencies of Th17 cells. In vitro studies were performed to evaluate the direct effects of cigarette smoke and PAH on Th17 differentiation. We also used mice genetically deficient for AHR (Ahr KO) and IL-17Ra (Il17ra KO) to determine the in vivo mechanism of smoking-induced arthritis aggravation.

resultsWe found that smoking induces arthritis aggravation and increase in the frequencies of Th17 cells. The absence of IL-17 signaling (Il17ra KO) conferred protection to smoking-induced arthritis aggravation. Moreover, in vitro experiments showed that cigarette smoke can directly increase Th17 differentiation of T cells by inducing AHR activation. Indeed, Ahr KO mice were protected from cigarette smoke-induced arthritis aggravation and did not display increase in TH17 frequencies, suggesting that AHR activation is an important mechanism for cigarette smoke effects on arthritis. Finally, we demonstrate that PAHs are also able to induce arthritis aggravation.

conclusionsOur data demonstrate that the disease-exacerbating effects of cigarette smoking are AHR dependent and environmental pollutants with AHR agonist activity can induce arthritis aggravation by directly enhancing Th17 cell development.

Indexed as

AnimalsArthritis, ExperimentalAzo CompoundsMaleMice, Inbred C57BLMice, Inbred DBAMice, KnockoutNicotianaPyrazolesReceptors, Aryl HydrocarbonReceptors, Interleukin-17SmokeTh17 Cells2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideAzo CompoundsIl17ra protein, mousePyrazolesReceptors, Aryl HydrocarbonReceptors, Interleukin-17SmokeCigarette smokeInflammationPolycyclic aromatic hydrocarbonsRheumatoid arthritisTh17

Identifiers

PMID29884199
PMCPMC5994132
OpenAlexW2806634761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.